Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.77 USD | -2.94% |
|
-2.79% | -10.95% |
05-23 | Supernus Pharmaceuticals Reports 'Clinical Utility' From Epilepsy Treatment Study | MT |
05-23 | Transcript : Supernus Pharmaceuticals, Inc. - Special Call |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.95% | 1.42B | |
+4.27% | 70.02B | |
+16.65% | 9.05B | |
+11.92% | 4.16B | |
-21.91% | 4.43B | |
+22.70% | 3.83B | |
+2.28% | 2.06B | |
+11.95% | 2.02B | |
-36.00% | 1.9B | |
-45.17% | 1.71B |
- Stock Market
- Equities
- SUPN Stock
- News Supernus Pharmaceuticals, Inc.
- Transcript : Supernus Pharmaceuticals, Inc. Presents at JP Morgan 37th Annual Healthcare conference, Jan-09-2019 10